RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 The Challenges of Pharmaceutical Management of Painful Diabetic Peripheral Neuropathy
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 16
SP 23
OP 23
DO 10.1177/155989771216011
UL http://mdc.sagepub.com/content/12/16/23.abstract
AB Diabetic peripheral neuropathy (DPN) affects up to 50% of patients with diabetes and is a major cause of morbidity and increased mortality. Its clinical manifestations, which include painful neuropathic symptoms and insensitivity, increase the risk for burns, injuries, and foot ulceration [Tesfaye S, Selvarajah D. Diabetes Metab Res Rev 2012]. This article discusses findings from recent studies on pharmaceutical agents used to treat DPN.